Screener
EBIT at other companies
Other financials
Where this comes from
Calculated from Amneal Pharmaceuticals, Inc.’s reported figures.
The source filing: Amneal Pharmaceuticals, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 5:19 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001723128-26-000031
FAQ
- What is Amneal Pharmaceuticals, Inc.'s EBIT?
- Amneal Pharmaceuticals, Inc. (AMRX) reported EBIT of $129.77M in Q2 2026.
- How has Amneal Pharmaceuticals, Inc.'s EBIT changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s EBIT increased by 16.5% year-over-year, from $111.37M to $129.77M.
- What is the long-term trend for Amneal Pharmaceuticals, Inc.'s EBIT?
- Over 4 years (2021 to 2025), Amneal Pharmaceuticals, Inc.'s EBIT has grown at a 26.7% compound annual growth rate (CAGR), from $152.72M to $394.1M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.
Ask your AI about Amneal Pharmaceuticals, Inc.'s ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude